The first and second month, of Axsome's first quarter of 2023 prescription data from IQVIA is below. Axsome's launch of Auvelity for MDD, has been strong to date.
1/06/2023 1300 2/03/2023 1850
1/13/2023 1650 2/10/2023 2499
1/20/2023 1835 2/17/2023 2380
1/27/2023 1750 2/24/2023 2546
